Percutaneous atrial Septal Occluder devices and cardiac erosion: A review of the literature

Catheterization and Cardiovascular Interventions

Volumn 80, Issue 2, 2012, Pages 157-167

  Crawford, Geoffrey B ^a   Brindis, Ralph G ^b   Krucoff, Mitchell W ^c   Mansalis, Benjamin P ^d   Carroll, John D ^e  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b Northern California Kaiser Permanente   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d KAISER PERMANENTE   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

amplatzer; ASD; complication; perforation; transcatheter

Indexed keywords

ATRIAL SEPTAL OCCLUDER; CASE STUDY; DEVICE SAFETY; DISEASE SEVERITY; FOOD AND DRUG ADMINISTRATION; HEART ATRIUM SEPTUM DEFECT; HEART DISEASE; HEART EROSION; HEART SURGERY; HUMAN; INCIDENCE; MEDLINE; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; REVIEW; SEPTAL OCCLUDER; SYSTEMATIC REVIEW; UNITED STATES;

ADOLESCENT; ADULT; AORTIC RUPTURE; CARDIAC CATHETERIZATION; CHILD; CHILD, PRESCHOOL; FEMALE; HEART ATRIA; HEART INJURIES; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; MALE; MIDDLE AGED; PROSTHESIS DESIGN; RISK ASSESSMENT; RISK FACTORS; SEPTAL OCCLUDER DEVICE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864283949     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24347     Document Type: Review

References (51)

1. United States Food and Drug Administration. Available at:. Accessed August 9, 2011.
2. United States Food and Drug Administration. Available at:. Accessed August 9, 2011.
3. Tateishi M, Hiramatsu T, Tomizawa Y, Matsumura G, Konuma T, et al. Cardiac tamponade due to perforation by an Amplatzer atrial septal occluder in a patient with Marfan syndrome. J Artif Organs 2011; 14: 261-263.
4. Kamouh A, Osman MN, Rosenthal N, Blitz A,. Erosion of an amplatzer septal occluder device into the aortic root. Ann Thorac Surg 2011; 91: 1608-1610.
5. Taggart NW, Dearani JA, Hagler DJ,. Late erosion of an Amplatzer septal occluder device 6 years after placement. J Thorac Cardiovasc Surg 2011; 142: 221-222.
6. Lopez-Fernandez T, Gomez de Diego JJ, Monedero MC, Cabestrero D, Mesa JM, et al. Aortic wall erosion after percutaneous closure of atrial septal defect. J Am Soc Echocardiogr 2011; 24: 227.e5-e8.
7. Sarris GE, Kirvassilis G, Zavaropoulos P, Belli E, Berggren H, et al. Surgery for complications of trans-catheter closure of atrial septal defects: a multi-institutional study from the European Congenital Heart Surgeons Association. Eur J Cardiothorac Surg 2010; 37: 1285-1290.
8. Ivens E, Hamilton-Craig C, Aroney C, Clarke A, Jalali H, et al. J Am Soc Echocardiogr 2009; 22: 1067-1070.
9. El-Said HG, Moore JW,. Erosion by the Amplatzer septal occluder: experienced operator opinions at odds with manufacturer recommendations? Catheter Cardiovasc Interv 2009; 73: 925-930.
10. DiBardino DJ, McElhinney DB, Kaza AK, Mayer JE Jr,. Analysis of the US Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. J Thorac Cardiovasc Surg 2009; 137: 1334-1341.
11. Bartus S, Sorysz D, Siudak Z, Dubiel JS, et al. Spontaneous closure of aorta-to-right atrium fistula after septal occluder implantation. J Cardiovasc Med (Hagerstown) 2008; 9: 744-746.
12. Loeffelbein F, Schlensak C, Dittrich S,. Penetration of left and right atrial wall and aortic root by an Amplatzer atrial septal occluder in a nine year old boy with Marfan syndrome: Case report. J Cardiothorac Surg 2008; 3: 25.
13. Awad SM, Garay FF, Cao QL, Hijazi ZM,. Multiple Amplatzer septal occluder devices for multiple atrial communications: immediate and long-term follow-up results. Catheter Cardiovasc Interv 2007; 70: 265-273. (Pubitemid 47208466)
14. Delaney JW, Li JS, Rhodes JF,. Major complications associated with transcatheter atrial septal occluder implantation: A review of the medical literature and the manufacturer and user facility device experience (MAUDE) database. Congenit Heart Dis 2007; 2: 256-264. (Pubitemid 47161798)
15. Maimon MS, Ratnapalan S, Do A, Kirsh JA, Wilson GJ, et al. Cardiac perforation 6 weeks after percutaneous atrial septal defect repair using an Amplatzer septal occluder. Pediatrics 2006; 118: e1572-e1575. (Pubitemid 46393706)
16. Sauer HH, Ntalakoura K, Haun C, Le TP, Hraska V,. Early cardiac perforation after atrial septal defect closure with the Amplatzer septal occluder. Ann Thorac Surg 2006; 81: 2312-2313. (Pubitemid 43775537)
17. Grayburn PA, Schwartz B, Anwar A, Hebeler RF Jr,. Migration of an amplatzer septal occluder device for closure of atrial septal defect into the ascending aorta with formation of an aorta-to-right atrial fistula. Am J Cardiol 2005; 96: 1607-1609. (Pubitemid 41690187)
18. Jang GY, Lee JY, Kim SJ, Shim WS, Lee CH,. Aorta to right atrial fistula following transcatheter closure of an atrial septal defect. Am J Cardiol 2005; 96: 1605-1606.
19. Knirsch W, Dodge-Khatami A, Balmer C, Peuster M, Kadner A, et al. Aortic sinus-left atrial fistula after interventional closure of atrial septal defect. Catheter Cardiovasc Interv 2005; 66: 10-13. (Pubitemid 41254597)
20. Mello DM, Fahey J, Kopf GS,. Repair of aortic-left atrial fistula following the transcatheter closure of an atrial septal defect. Ann Thorac Surg 2005; 80: 1495-1498. (Pubitemid 41354149)
21. Vojacek J, Mates M, Popelova J, Pavel P,. Perforation of the right atrium and the ascending aorta following percutaneous transcatheter atrial septal defect closure. Interact Cardiovasc Thorac Surg 2005; 4: 157-159. (Pubitemid 41289167)
22. Divekar A, Gaamangwe T, Shaikh N, Raabe M,. Cardiac perforation after device closure of atrial septal defects with the Amplatzer septal occluder. J Am Coll Cardiol 2005; 45: 1213-1218. (Pubitemid 40523139)
23. Preventza O, Sampath-Kumar S, Wasnick J, Gold JP,. Late cardiac perforation following transcatheter atrial septal defect closure. Ann Thorac Surg 2004; 77: 1435-1437. (Pubitemid 38452397)
24. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand WE, Kleinman CS,. Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk. Catheter Cardiovasc Interv 2004; 63: 496-502. (Pubitemid 39578516)
25. Chun DS, Turrentine MW, Moustapha A, Hoyer MH,. Development of aorta-to-right atrial fistula following closure of secundum atrial septal defect using the Amplatzer septal occluder. Catheter Cardiovasc Interv 2003; 58: 246-251. (Pubitemid 36159572)
26. Aggoun Y, Gallet B, Acar P, Pulik M, Czitrom D, et al. Perforation of the aorta after percutaneous closure of an atrial septal defect with an Amplatz prosthesis, presenting with acute severe hemolysis. Arch Mal Coeur Vaiss 2002; 95: 479-482. (Pubitemid 34563796)
27. Chessa M, Carminati M, Butera G, Bini RM, Drago M, et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect. J Am Coll Cardiol 2002; 39: 1061-1065. (Pubitemid 34234131)
28. Qureshi AM, Mumtaz MA, Latson LA,. Partial prolapse of a HELEX device associated with early frame fracture and mitral valve perforation. Catheter Cardiovasc Interv 2009; 74: 777-782.
29. Misra M, Sadiq A, Namboodiri N, Karunakaran J,. The 'aortic rim' recount: embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure. Interact Cardiovasc Thorac Surg 2007; 6: 384-386. (Pubitemid 46849712)
30. Brown S, Gewillig M,. Perforation of the aortic sinus after closure of atrial septal defects with the Atriasept occluder. Catheter Cardiovasc Interv. 2009; 74: 298-301.
31. Murphy JC, Walsh SJ, Spence MS,. Late aortic perforation with an Atriasept device resulting in life-threatening tamponade. Catheter Cardiovasc Interv. 2010; 76: 132-134.
32. Trepels T, Zeplin H, Sievert H, Billinger K, Krumsdorf U, et al. Cardiac perforation following transcatheter PFO closure. Catheter Cardiovasc Interv 2003; 58: 111-113. (Pubitemid 36055315)
33. Cecconi M, Quarti A, Bianchini F, Bucari S, Costantini C, et al. Late cardiac perforation after transcatheter closure of patent foramen ovale. Ann Thorac Surg 2006; 81: e29-e30. (Pubitemid 43775603)
34. Amin Z, Hijazi ZM, Bass JL, Cheatham JP, Hellenbrand W, et al. PFO closure complications from the AGA registry. Catheter Cardiovasc Interv 2008; 72: 74-79. (Pubitemid 352008987)
35. Christen T, Mach F, Didier D, Kalangos A, Verin V, et al. Late cardiac tamponade after percutaneous closure of a patent foramen ovale. Eur J Echocardiogr. 2005; 6: 465-469. (Pubitemid 41700717)
36. Stauffer JC, Serra M, Juillard JM, Seydoux C, Perret F, et al. Percutaneous closure of patent foramen ovale: preliminary experience with the PFO Star. [Article in French] Arch Mal Coeur Vaiss. 2004; 97: 37-41. (Pubitemid 38155594)
37. Meier JM, Nasratullah M, Eeckhout E,. Late spontaneous resolution of iatrogenic fistula between right atrium and aorta secondary to percutaneous closure of patent foramen ovale. Eur J Echocardiogr. 2007; 8: 57-9. (Pubitemid 46112104)
38. Lange SA, Schoen SP, Braun MU, Schulze MR, Boscheri AF, et al. Perforation of aortic root as secondary complication after implantation of patent foramen ovale occlusion device in a 31-year-old woman. J Interv Cardiol 2006; 19: 166-169.
39. Raffa GM, Pellegrini C, Lentini S, Perrotta S, Tancredi F, et al. Minimally invasive video-assisted surgery for iatrogenic aortic root-to-right atrium fistula after incomplete percutaneous occlusion of patent foramen ovale: case report and review of the literature. J Card Surg 2008; 23: 75-78. (Pubitemid 351286908)
40. Schoen SP, Wiedeman S, Bock M, Kappert U, Strasser RH,. Interatrial septal closure devices and aortic perforation: a note of caution. J Invasive Cardiol 2009; 21: E39-E41.
41. Girdauskas E, Diab M, Secknus MA, Borger MA, Kuntze T,. Late cardiac perforation after transcatheter closure of patent foramen ovale mimicking acute type a aortic dissection. Ann Thorac Surg 2010; 89: 1649-1651.
42. Motreff P, Dauphin C, Souteyrand G,. Cardiac perforation and tamponade 3 months after transcatheter PFO closure by STARFlex device: A case report. Catheter Cardiovasc Interv 2008; 71: 412-416. (Pubitemid 351428166)
43. Rigatelli G, Cardaioli P, Giordan M, Dell'Avvocata F, Braggion G, et al. Transcatheter intracardiac echocardiography-assisted closure of interatrial shunts: Complications and midterm follow-up. Echocardiography 2009; 26: 196-202.
44. Kitano M, Yazaki S, Sugiyama H, Yamada O,. The influence of morphological changes in amplatzer device on the atrial and aortic walls following transcatheter closure of atrial septal defects. J Interv Cardiol 2009; 22: 83-91.
45. Wilson NJ, Smith J, Prommete B, O'Donnell C, Gentles TL, et al. Transcatheter closure of secundum atrial septal defects with the Amplatzer septal occluder in adults and children-follow-up closure rates, degree of mitral regurgitation and evolution of arrhythmias. Heart Lung Circ 2008; 17: 318-324.
46. Post MC, Van Deyk K, Budts W,. Percutaneous closure of a patent foramen ovale: single-centre experience using different types of devices and mid-term outcome. Acta Cardiol 2005; 60: 515-519. (Pubitemid 41433658)
47. Carroll JD,. Device erosion. Catheter Cardiovasc Interv 2009; 73: 931-932.
48. Carroll J,. World Wide Analysis of Tissue Erosion and ASO. Presented at: Transcatheter Cardiovascular Therapeutics November 7-11, 2011.
49. Available at: https://www.ncdr.com/webncdr/DefaultCathPCI.aspx. Accessed September 29, 2011.
50. Resnic FS, Gross TP, Marinac-Dabic D, Loyo-Berrios N, Donnelly S, et al. Automated surveillance to detect postprocedure safety signals of approved cardiovascular devices. JAMA 2010; 304: 2019-2027.
51. Food and Drug Administration. Information for physicians and patients on the withdrawal of two humanitarian device exemptions (HDEs) For Patent Foramen Ovale (PFO) Occluders. Available at:. Last accessed August 18, 2011.